Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP2D6 Genotype and Primaquine PK in Active Duty Military
NCT02960568Phase 1Completed
- Sponsor
- Walter Reed Army Institute of Research
- Start
- Jan 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of primaquine in malaria (2 arms), sponsored by Walter Reed Army Institute of Research. Primary endpoints: Description of CYP2D6 alleles in an active duty population at 1 hour, Measure concentrations of plasma primaquine and its major metabolites at 24 hours and 1 more. Started Jan 2016; status: completed.
02
Drugs
primaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02960568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02960568.